Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Portage Biotech Inc Ord (PRTG)

Portage Biotech Inc Ord (PRTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Portage Biotech Inc Ord Craigmuir Chambers Road Town Tortola D8 VG1110

www.portagebiotech.com P: 416-929-1806

Description:

Portage Biotech Inc. is a clinical stage immuno-oncology company focused on overcoming immune resistance. The company source, nurture and develop therapies for a variety of cancers. Its drug development pipeline portfolio encompasses products or technologies with established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

Key Statistics

Overview:

Market Capitalization, $K 4,824
Enterprise Value, $K -5,726
Shares Outstanding, K 17,801
Annual Sales, $ 0 K
Annual Net Income, $ -104,610 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -39,370 K
EBIT, $ -19,040 K
EBITDA, $ -19,040 K
60-Month Beta 1.20
% of Insider Shareholders 42.07%
% of Institutional Shareholders 13.36%
Float, K 10,312
% Float 57.93%
Short Volume Ratio 0.52

Growth:

1-Year Return -91.40%
3-Year Return -99.03%
5-Year Return -96.77%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 02/28/24
Latest Earnings Date 03/06/24
Earnings Per Share ttm -6.64
EPS Growth vs. Prev Qtr 37.93%
EPS Growth vs. Prev Year 59.09%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 06/04/20

PRTG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -177.66%
Return-on-Assets % -129.14%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.15
Book Value/Share 1.76
Interest Coverage -12,251.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar